Parameter | Cost |
---|---|
Direct ophthalmic medical costs | Â |
 Ranibizumab therapy (81.3% bilateral) | $79,056 |
Direct non-ophthalmic medical costs | |
 Injury reduction | (−$664) |
 Depression reduction | (−$2543) |
 SNF cost decrease | (−$4100) |
 Unexplained medical cost decrease | (−$28,598) |
 Nursing home | (−$19,069) |
 Total offsetting costs | (−$54,974) |
 Total direct medical costs | $24,082 |
Direct non-medical costs | |
 Paid caregiver salariesa | (−$82,419) |
 Salary gain for freed-up caregivers now able to take up gainful employment | (−$215,123) |
 Total direct non-medical costs | (−$297,542) |
Indirect medical costs | |
 Mean patient wage gain | (−$9057) |
 Total societal costs | (−$282,517) |